2IT-BAD monoclonal antibody 170
Term · Oncology and biomedicine · MLC-T-ONC-000038
A substance being studied in the treatment of cancer. It is made by linking a monoclonal antibody called 170, which binds to a protein called MUC-1, to a substance called 2IT-BAD, which binds radioactive substances. 2IT-BAD monoclonal antibody 170 may be used to detect cancer cells and kill them. It is a type of immunoconjugate.
| Identifier | MLC-T-ONC-000038 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000038",
"term": "2IT-BAD monoclonal antibody 170",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. It is made by linking a monoclonal antibody called 170, which binds to a protein called MUC-1, to a substance called 2IT-BAD, which binds radioactive substances. 2IT-BAD monoclonal antibody 170 may be used to detect cancer cells and kill them. It is a type of immunoconjugate.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/2it-bad-monoclonal-antibody-170/"
}
Record 59 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.